Qube Research & Technologies (QRT)’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$481K Sell
20,400
-6,009
-23% -$124K ﹤0.01% 2666
2026
Q1
$454K Buy
+26,409
New +$543K ﹤0.01% 2769
2024
Q3
Sell
-89
Closed -$2.51K 4038
2024
Q2
$2.51K Hold
89
﹤0.01% 3159
2024
Q1
$3.29K Buy
89
+16
+22% +$598 ﹤0.01% 3945
2023
Q4
$3K Buy
+73
New +$2.34K ﹤0.01% 3784
2023
Q2
Sell
-6,469
Closed -$267K 2964
2023
Q1
$267K Buy
+6,469
New +$273K ﹤0.01% 1814

Other funds holding SMTI

Qube Research & Technologies (QRT)'s SMTI Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Sanara MedTech (SMTI) stake by 23% in Q2 2026, selling an estimated $124K and leaving 20,400 shares worth $481K. The position accounts for ﹤0.01% of the portfolio, ranked #2666.

Qube Research & Technologies (QRT) first reported a position in SMTI in Q1 2023 and has held it in 6 quarters since. 75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Qube Research & Technologies (QRT) held 20,400 shares of Sanara MedTech worth $481K as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 6,009 Sanara MedTech shares in Q2 2026, an estimated $124K.
  • Sanara MedTech made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2666 holding.
  • Qube Research & Technologies (QRT) first reported a position in Sanara MedTech in Q1 2023 and has held it in 6 quarters since.
  • 75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.